Last $56.70 USD
Change Today +0.46 / 0.82%
Volume 308.8K
OKS On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gil J. Van Lunsen

Director, Chairman of Audit Committee and Member of Corporate Governance Committee, Array BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 4 different organizations across 5 different industries.

See Board Relationships
71$102,458

Background*

Mr. Gil J. Van Lunsen served as a Managing Partner of KPMG LLP and led its Tulsa, Oklahoma office, since 1994. Mr. Van Lunsen retired from KPMG LLP in June 2000 following 32 years of service. Nine years after joining KPMG in 1968 as an Assistant Accountant, he became Partner and subsequently was promoted to Partner in charge of national accounting and audit training. He transferred to the Tulsa Oklahoma office in July 1980. In addition, he was the audit committee chairman ...

Read Full Background

Corporate Headquarters*

100 West Fifth Street
Tulsa, Oklahoma 74103

United States

Phone: 918-588-7000
Fax: --

Board Members Memberships*

Director
2001-N/A
Former Director
2002-Present
Director, Chairman of Audit Committee and Member of Corporate Governance Committee
2003-N/A
Former Director, Chairman of Audit Committee and Member of Nominating Committee
2006-Present
Director of Oneok Partners GP LLC, Chairman of Audit Committee and Chairman of Conflicts Committee
2010-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee

Education*

BSBA 1968
University of Denver

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$49,500
Total Calculated Compensation$102,458
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OKS:US $56.70 USD +0.46

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
Cell Therapeutics, Inc.
$1.3M
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Werner Lanthaler MBA/MPAChief Executive Officer
Evotec AG
€601.0K
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONEOK PARTNERS LP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.